170 related articles for article (PubMed ID: 18540977)
1. Expression of leukaemia inhibitory factor in epithelial ovarian carcinoma: correlation with clinical characteristics.
Ye F; Hu Y; Lu W; Zhou C; Xie X
Histopathology; 2008 Aug; 53(2):224-8. PubMed ID: 18540977
[No Abstract] [Full Text] [Related]
2. [Morphometrical and immunohistochemical criteria of prognosis in patients with serous and mucinous ovarian carcinoma].
Kolosov AE; Novichkov EV
Arkh Patol; 2003; 65(5):29-32. PubMed ID: 14664145
[TBL] [Abstract][Full Text] [Related]
3. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
[TBL] [Abstract][Full Text] [Related]
5. TTF-1 expression in primary ovarian epithelial neoplasia.
Graham AD; Williams AR; Salter DM
Histopathology; 2006 May; 48(6):764-5. PubMed ID: 16681695
[No Abstract] [Full Text] [Related]
6. [Expression of hSef and FGF-2 in epithelial ovarian tumor].
Feng QL; Shi HR; Qiao LJ; Zhao J
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
Yang YQ; Li JC
Ai Zheng; 2006 Jun; 25(6):713-7. PubMed ID: 16764766
[TBL] [Abstract][Full Text] [Related]
8. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
Cao LQ; Chen XM; Li X
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of detecting telomerase activity in ascites cells from patients with ovarian carcinoma].
Jin S; Zhang W; Wang H; Liu Y; Gao F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Dec; 21(6):455-9. PubMed ID: 12567493
[TBL] [Abstract][Full Text] [Related]
10. [Significance and mechanisms of overexpression of PAK1 gene in epithelial ovarian neoplasms].
Xie D; Yang GF; Chen YQ; Jiang LF; Xiao LZ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):911-4. PubMed ID: 17533742
[TBL] [Abstract][Full Text] [Related]
11. Serous and mucinous borderline ovarian tumors: are there real differences between these two entities?
Benito V; Lubrano A; Arencibia O; Medina N; Álvarez Eva E; Andújar M; Falcón Juan M; Falcón O
Eur J Obstet Gynecol Reprod Biol; 2010 Dec; 153(2):188-92. PubMed ID: 20728981
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of laminin isoforms in ovarian epithelial carcinomas suggesting different origin and providing tools for differential diagnosis.
Määttä M; Bützow R; Luostarinen J; Petäjäniemi N; Pihlajaniemi T; Salo S; Miyazaki K; Autio-Harmainen H; Virtanen I
J Histochem Cytochem; 2005 Oct; 53(10):1293-300. PubMed ID: 15923364
[TBL] [Abstract][Full Text] [Related]
13. [Detection of CDX-2, CK7 and CK20 in primary and metastatic ovarian carcinoma].
Yuan ZF; Shi HR; Sun HM; Li WC
Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):555-6. PubMed ID: 17980105
[No Abstract] [Full Text] [Related]
14. TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
El-Balat A; Schmeil I; Karn T; Becker S; Sänger N; Holtrich U; Arsenic R
Pathol Oncol Res; 2018 Apr; 24(2):277-282. PubMed ID: 28470574
[TBL] [Abstract][Full Text] [Related]
15. [Ovarian cancer prognosis and expression of receptors to sex hormones and proliferative activity of tumor cells].
Novichkov EV; Votintsev AA
Arkh Patol; 2006; 68(2):10-3. PubMed ID: 16752501
[TBL] [Abstract][Full Text] [Related]
16. [Expression of macrophage migration inhibitory factor, p53 and CD34 in ovarian carcinoma].
He CZ; Xia XA; Wu YY; Pu H; Lü B; Mao YR; Zhang ZY; Gao WH
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):261-2. PubMed ID: 17706119
[No Abstract] [Full Text] [Related]
17. [Study on expression of proliferating cell nuclear antigen (PCNA) in ovarian cancer].
Terauchi F; Ueno R; Tanabe K; Ogura H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Nov; 48(11):1058-62. PubMed ID: 8940694
[TBL] [Abstract][Full Text] [Related]
18. Expression of gonadotropin-releasing hormone receptor in human epithelial ovarian carcinoma.
Imai A; Ohno T; Ohsuye K; Tamaya T
Ann Clin Biochem; 1994 Nov; 31 ( Pt 6)():550-5. PubMed ID: 7880073
[TBL] [Abstract][Full Text] [Related]
19. [Expression of IL10 in epithelial ovarian tumor tissue and cell line and its clinical significance].
Zhou JW; Qian YS; Xie X; Lu WG; Chen HZ
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1911-3. PubMed ID: 15631806
[No Abstract] [Full Text] [Related]
20. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
Liu C; Zhao Y; Sun X
Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
